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Abstract
Coenzyme Q (CoQ) is an essential electron carrier in the respiratory chain whose deficiency has been implicated in a wide
variety of human mitochondrial disease manifestations. Its multi-step biosynthesis involves production of polyisoprenoid
diphosphate in a reaction that requires the enzymes be encoded by PDSS1 and PDSS2. Homozygous mutations in either of
these genes, in humans, lead to severe neuromuscular disease, with nephrotic syndrome seen in PDSS2 deficiency. We now
show that a presumed autoimmune kidney disease in mice with the missense Pdss2kd/kd genotype can be attributed to a
mitochondrial CoQ biosynthetic defect. Levels of CoQ9 and CoQ10 in kidney homogenates from B6.Pdss2
kd/kd mutants were
significantly lower than those in B6 control mice. Disease manifestations originate specifically in glomerular podocytes, as
renal disease is seen in Podocin/cre,Pdss2loxP/loxP knockout mice but not in conditional knockouts targeted to renal tubular
epithelium, monocytes, or hepatocytes. Liver-conditional B6.Alb/cre,Pdss2loxP/loxP knockout mice have no overt disease
despite demonstration that their livers have undetectable CoQ9 levels, impaired respiratory capacity, and significantly
altered intermediary metabolism as evidenced by transcriptional profiling and amino acid quantitation. These data suggest
that disease manifestations of CoQ deficiency relate to tissue-specific respiratory capacity thresholds, with glomerular
podocytes displaying the greatest sensitivity to Pdss2 impairment.
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Introduction
Coenzyme Q (CoQ) is a benzoquinone molecule with a
polyisoprenylated side chain that ranges from 6 to 10 isoprenyl
units in length. It functions as an electron carrier in the
mitochondrial respiratory chain, where it transports electrons
from complexes I or II to complex III. The polyisoprenyl
diphosphate synthases which form the isoprenyl side chain of
CoQ in mice and humans are each heterotetramers of two protein
subunits [1]. The genes that encode these subunits are now
designated Pdss1 and Pdss2 in mice, and PDSS1 and PDSS2 in
humans. Although its identity was not understood at the time, the
first known mutation in the Pdss2 gene arose spontaneously in the
CBA/CaH colony of Dr. Mary Lyon and was designated kidney
disease (kd). Homozygotes for the kd allele develop a lethal disease
characterized by tubulointerstitial nephritis, dilated tubules, and
proteinuria [2]. Mutant kd/kd homozygotes appear healthy for at
least the first 8 weeks of life, but histological examination of the
kidneys beginning at about 12 weeks of life reveals a mononuclear
cell infiltrate and tubular dilatation with proteinaceous casts in
cortical areas. Over time this extends to involve the entire kidney
with resultant renal failure [3,4,5].
Renal disease pathogenesis was initially thought to be immune
mediated, rather than resulting from a structural or developmental
defect [3,6]. However, we have since shown that the same renal
disease, including leukocytic infiltration of macrophages and
natural killer cells, develops spontaneously in kd/kd;Rag-12/2
double homozygotes lacking functional T and B lymphocytes [7].
Furthermore, mutant kd/kd mice are now recognized to have
features of collapsing glomerulopathy (CG), a unique glomerular
morphology in which hyperplastic and hypertrophic podocytes
overlie collapsed capillary loops. While interstitial nephritis is often
present in CG, no single definable pathogenic trigger for this
disease has emerged [8]. Dysregulation of podocyte terminal
differentiation in kd/kd mice was demonstrated by de novo
expression of cyclin D1 (marking cell-cycle engagement) and Ki-
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67 (indicating podoctye cell-cycle progression), with loss of
expression of differentiation markers WT-1 and synaptopodin
[9]. These results suggested that there may indeed be an intrinsic
structural defect in the podocytes of kd/kd mice, with the
inflammatory reaction playing only a secondary role.
A positional cloning approach demonstrated that the kd allele is
a missense mutation in a prenyltransferase-like mitochondrial
protein [10], now designated Pdss2. This enzyme forms a
heterotetramer with another enzyme encoded by Pdss1 to generate
nonaprenyl diphosphate in mice or decaprenyl diphosphate in
humans. The polyisoprenoid diphosphate precursor is added to 4-
hydroxybenzoic acid, forming polyisoprenyl-hydroxybenzoic acid,
an early intermediate in CoQ biosynthesis [1]. Compound
heterozygous PDSS2 mutations were recently identified in a child
with severe Leigh syndrome and nephrotic syndrome [11].
Primary CoQ deficiency in humans is a rare condition that
typically presents with neurologic or myopathic disease that is
often ameliorated with CoQ supplementation [12]. It has now
been associated with mutations in three of the nine nuclear genes
encoding component enzymes of the CoQ biosynthesis pathway
including COQ2, PDSS1, and PDSS2 [11,13,14,15] as well as with
electron-transferring-flavoprotein dehydrogenase (ETFDH) muta-
tions affecting the transfer of electrons to CoQ [16]. Nephrotic
syndrome has been seen in individuals with mutations in PDSS2
[11], as well as COQ2 [13,14,17]. Mechanisms underlying tissue-
specific disease manifestations remain unclear.
We report here results of extensive phenotypic characterizations
of both kd/kd (B6.Pdss2kd/kd) missense and tissue-specific condi-
tional Pdss2 knockout mice, including those affecting renal
glomerular podocytes (B6.Podocin/cre,Pdss2loxP/loxP), renal tubular
epithelium and hepatocytes (B6.PEPCK/cre,Pdss2loxP/loxP), mono-
cytes (B6.LysM/cre,Pdss2loxP/loxP), and hepatocytes (B6.Alb/cre,
Pdss2loxP/loxP). This work demonstrates that renal disease in
Pdss2kd/kd mice results from podocyte-specific Pdss2 dysfunction.
In addition, while biochemical evidence of significant CoQ
deficiency, respiratory chain dysfunction in isolated mitochondria,
and altered amino acid profiles is present in livers of both
B6.Pdss2kd/kd missense and B6.Alb/cre,Pdss2loxP/loxP mutant mice, no
overt manifestations of liver or other extra-renal disease were
observed in any of the mutants through eight months of life.
Results
Pdss2kd/kd Phenotype Is Recapitulated in B6.Podocin/
cre,Pdss2loxP/loxP Mice
The Pdss2loxP construct was prepared as shown in Figure 1. The
total knockout (B6.Zp3/Cre,Pdss2loxP/loxP) was embryonically lethal ,
with no homozygous embryos surviving beyond 10.5 days of
gestation (data not shown). This is in agreement with the findings
of Levavasseur et al. [18] and Nakai et al. [19], who reported that
mouse embryos deficient in CoQ synthesis as a result of clk-1/coq7
(demethoxyubiquinone hydroxylase) mutations also arrest devel-
opment at mid-gestation. Tissue-specific conditional knockouts
were therefore generated by crossing B6.Pdss2loxP/loxP mice with
several Cre-expressing strains. As shown in Figure 2, the Pdss2 gene
was successfully targeted in the glomeruli but not the collecting
tubules of B6.Podocin/cre,Pdss2loxP/loxP mice, whereas the collecting
tubules and hepatocytes but not the glomeruli were targeted in
B6.PEPCK/cre,Pdss2loxP/loxP mice.
B6.Podocin/cre,Pdss2loxP/loxP but not B6.PEPCK/cre,Pdss2loxP/loxP
mice had the same kidney disease phenotype as B6.Pdss2kd/kd
missense mice, as judged by albuminuria and histological evidence
of nephritis. Sections of kidneys from B6.Podocin/cre,Pdss2loxP/loxP
mice, B6.PEPCK/cre,Pdss2loxP/loxP mice, and controls are shown in
Figure 3. The phenotype of B6.Podocin/cre,Pdss2loxP/loxP is histolog-
ically indistinguishable from that of a B6.Pdss2kd/kd missense
mutant, with both showing greatly dilated tubules and extensive
interstitial infiltration. In contrast, neither feature is seen in the
B6.PEPCK/cre,Pdss2loxP/loxP or the B6.Pdss2loxP/loxP control. Renal
tissue from conditional knockouts was also examined by electron
microscopy, with results shown in Figure 4. No significant
ultrastructural differences were observed between B6 and
B6.Pdss2loxP/loxP control kidneys (Figures 4A and 4C), but the
abnormalities present in the B6.Podocin/cre,Pdss2loxP/loxP knockout
(Figure 4D) were the most extensive of any Pdss2 mutant studied
[10]. Measurements of 24-hour urine albumin and semi-
quantitative histological scores from Pdss2 missense, all conditional
knockout mutants, as well as controls, are shown in Table 1. Only
the B6.Podocin/cre,Pdss2loxP/loxP knockouts had a phenotype that
resembled that of the B6.Pdss2kd/kd mice, as measured by either
albuminuria or histologically-scored nephritis.
Another phenotypic abnormality seen in B6.Pdss2kd/kd homozy-
gotes is elevated serum cholesterol and triglycerides [20]. In an
effort to determine whether this alteration may in part result from
the underlying biochemical defect in CoQ biosynthesis rather than
wholly as a consequence of nephrotic syndrome, we measured
cholesterol and triglyceride levels in B6.Podocin/cre,Pdss2loxP/loxP
and B6.Alb/cre,Pdss2loxP/loxP mice. B6.Podocin/cre,Pdss2loxP/loxP mice
developed renal disease associated with significantly elevated plasma
cholesterol levels (Table 2), suggesting hypercholesterolemia is
largely a consequence of nephrotic syndrome. However, significantly
elevated plasma cholesterol was also seen in B6.Alb/cre,Pdss2loxP/loxP
(94 +/2 7.1 mg/dl) when compared with B6.Pdss2loxP/loxP controls
(61 +/2 5.5 mg/dl), suggesting that a Pdss2 defect in the hepatocytes
does contribute to hypercholesterolemia.
Pdss2 Mutations Diminish CoQ Tissue Levels
CoQ content was determined in lipid extracts of tissue
homogenates from livers and kidneys dissected from mutant and
control mice. As shown in Figure 5 (Panel A), there was a
significant reduction in CoQ9 and CoQ10 levels in the kidneys of
B6.Pdss2kd/kd mice compared to age-matched B6 controls. There
were no significant differences in kidney CoQ9 content between
the B6, B6.Pdss2loxP/+, or B6.Pdss2loxP/loxP control mice (Panels A
and B). Neither the B6.Podocin/cre,Pdss2loxP/loxP nor the B6.PEPCK/
Author Summary
Coenzyme Q is a critical component of the mitochondrial
respiratory chain, the process by which cells make energy.
Coenzyme Q deficiency in humans causes a wide range of
disease manifestations affecting the nervous system, mus-
cles, and kidneys. Here, we show that the failure to make
Coenzyme Q due to a Pdss2mutation is the cause of a lethal
kidney disease in mice that was previously thought to result
from an autoimmune process. Studying both a spontane-
ously occurring missense mutant and a series of mutants
generated to have the Coenzyme Q deficiency targeted
solely to liver, kidney, or macrophages, we show that the
specific cell type in which the kidney disease arises is the
glomerular podocyte. No other manifestations of disease are
evident in these animals. However, our analysis of livers from
these mice reveals that they have significant depletion of
Coenzyme Q, impairment of mitochondrial respiratory chain
function, and disturbance of many other basic metabolic
processes. Similar microarray patterns of cellular alterations
to primary mitochondrial dysfunction were seen both in
these mice and in a previously reported nematode model,
suggesting that a common cellular profile of primary
respiratory chain function may exist across evolution.
Renal Disease in Pdss2 Mutant Mice
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Figure 2. Pdss2 Conditional Knockout Confirmation. PCR products after laser capture microdissection, using primers for exon 2 (A) or exon 4
(B). Lanes: 1, Pdss2loxP/loxP glomerulus; 2, Pdss2loxP/loxP tubules; 3, B6.Podocin/cre,Pdss2loxP/loxP mouse 1, glomerulus; 4, B6.Podocin/cre,Pdss2loxP/loxP
mouse 1 tubules; 5, B6.Podocin/cre,Pdss2loxP/loxP mouse 2, glomerulus; 6, B6.Podocin/cre,Pdss2loxP/loxP mouse 2 tubules; 7, B6.PEPCK/cre,Pdss2loxP/loxP
mouse 1 glomerulus; 8, B6.PEPCK/cre,Pdss2loxP/loxP mouse 1, tubules; 9, B6.PEPCK/cre,Pdss2loxP/loxP mouse 2 glomerulus; 10, B6.PEPCK/cre,Pdss2loxP/loxP
mouse 2, tubules.
doi:10.1371/journal.pgen.1000061.g002
Figure 1. Generation of a Pdss2 Conditional Null Allele. Generation of a Pdss2 conditional null allele, showing a map of the Pdss2 genomic
locus and the targeting vector with exons represented by open boxes. The relative position of PCR primers (small arrowheads), loxP (large
arrowheads), as well as cassettes encoding neomycin phosphotransferase (neo) are shown. Primers koF, koF2 and koR were used in PCR genotype
analysis. Cre-mediated deletion results in either the Pdss2 null allele (deletion of exon 3 ) or the Pdss2 loxP/loxP allele (exon 2 flanked by loxP sites).
Abbreviations: Ba, BamH I; Aa. Aat II; Xh, Xho I; Dr, Dra III.
doi:10.1371/journal.pgen.1000061.g001
Renal Disease in Pdss2 Mutant Mice
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cre,Pdss2loxP/loxP mice had a significant reduction in the CoQ9
levels of total liver or kidney homogenates (Panels B and C),
which is consistent with the fact that only a small subset of
cells were affected by these targeted disruptions. However, the
B6.Alb/cre,Pdss2loxP/loxP mice had less than 30 pmol CoQ9 per
mg liver protein, which would be expected if most
hepatic cells were affected by the albumin promoter-driven Cre
expression.
Pdss2 Mutations Do Not Consistently Alter Pdss1
Expression in Liver or Whole Kidney
Relative quantitation expression studies in isolated liver tissue
demonstrated significant Pdss2 knock-down in each of three
B6.Alb/cre,Pdss2loxP/loxP mutants (mean 97.2% decrease; range
97.0% to 97.3% decrease), but no consistent change in nine
B6.Pdss2kd/kd missense mice (mean 6% increase; range 40%
decrease to 250% increase) in comparison with appropriate strain-
and age-matched pooled controls. Pdss1 expression showed
inconsistent alterations both among six B6.Alb/cre,Pdss2loxP/loxP
mutants (mean 21% increase; range 50% decrease to 180%
increase) as well as nine B6.Pdss2kd/kd missense mutants (mean 4%
decrease; range 22% decrease to 57% increase) in comparison
with pooled Pdss2loxP/loxP or B6 respective controls. Finally, relative
quantitation demonstrated a decrease in expression of both Pdss1
and Pdss2 transcripts in RNA isolated from intact single kidneys of
three B6.Pdss2kd/kd missense mutants with renal disease [(Pdss1
mean 71% decrease; range 65% to 80% decrease) and (Pdss2
mean 35% decrease; range 26% to 44% decrease)], but no
consistent alteration of either transcript in RNA isolated from
intact single kidneys of three B6.Podocin/cre,Pdss2loxP/loxP mutants
with renal disease [(Pdss1 mean 31% decrease; range 75%
decrease to 55% increase) and (Pdss2 mean 17% increase; range
4% decrease to 57% increase)].
Pdss2 Mutations Impair Mitochondrial Respiratory Chain
Function
B6.Alb/cre,Pdss2loxP/loxP mice had no evidence of disease through
8 months of life, but isolated liver mitochondria respiratory chain
capacity in 6 to 8 month old animals was impaired to a similar
extent as seen in B6.Pdss2kd/kd missense mice. Specifically,
polarography of freshly isolated liver mitochondria showed
significantly decreased complex I- and complex II-dependent
integrated respiratory chain capacity in both B6.Pdss2kd/kd and
B6.Alb/cre,Pdss2loxP/loxP mutants compared with controls (Figure 6,
panels A and B). Significantly increased complex IV-dependent
respiratory capacity was also observed in both the B6.Pdss2kd/kd
and B6.Alb/cre,Pdss2loxP/loxP mutants (Figure 6, panel C). This
suggests that the degree of CoQ deficiency in liver is sufficient to
cause secondary upregulation of respiratory chain components
(complex IV) distal to the genetic deficiency (CoQ). These
functional alterations are supported by spectrophotometric
electron transport chain enzyme activity analyses performed on
frozen liver mitochondria from these same animals (Figure 6,
Panel D). Frozen mitochondria isolated from single whole kidney
Figure 3. Histologic Features of Renal Disease in Pdss2Mutant and Control Mice. Histologic features of renal disease in mutant and control
mice (H & E-stained sections, original magnifications all 200x). A, B6.Podocin/cre,Pdss2loxP/loxP mouse (290 days old; 64 mg albumin; histologic score,
4+). B, B6.PEPCK/cre, Pdss2loxP/loxP (191 days old; 0.04 mg albumin; histologic score 0). C, B6.Pdss2kd/kd (146 days old; 15 mg albumin; histologic score,
3+). D, B6. Pdss2loxP/loxP mouse, (191 days old; 0.12 mg albumin; histologic score, 0). Note the prominent tubular dilatation and interstitial infiltrates in
panels A and C, but absent in panels B and D.
doi:10.1371/journal.pgen.1000061.g003
Renal Disease in Pdss2 Mutant Mice
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homogenates were also studied from five B6 and three
B6.Pdss2loxP/loxP controls, as well as three animals each of
genotypes B6.Pdss2kd/kd, B6.Podocin/cre,Pdss2loxP/loxP, B6.PEPCK/
cre, Pdss2loxP/loxP, and B6.Alb/cre,Pdss2loxP/loxP. No significant
differences were detected in activities of enzyme complex I-III,
II-III, III, or IV normalized to citrate synthase activity for any of
the mutants in comparison with controls, although a trend toward
increase was observed for complex IV enzyme activity in
B6.Pdss2kd/kd kidney mitochondria (data not shown).
Metabolic Effects of Pdss2 Liver Conditional Knockout
A significantly altered metabolic phenotype at the level of
concordant biochemical pathway expression changes was clearly
present in B6.Alb/cre,Pdss2loxP/loxP mutants by 6 months of life, as
summarized in Figure 7 (left column). Specific metabolic
consequences of Pdss2-based CoQ deficiency include significant
upregulation at a nominal p-value,0.05 in 43 of 95 essential
KEGG biochemical pathways analyzed by Gene Set Enrichment
Analysis including oxidative phosphorylation itself, the tricarbox-
ylic acid (TCA) cycle, and multiple metabolic pathways that
provide substrates necessary for energy production including fatty
acid metabolism and 8 different amino acid metabolic pathways.
Many of these same pathways were similarly upregulated upon
expression profiling of C. elegans mitochondrial mutants in nuclear-
encoded respiratory chain subunits of complexes I, II, and III
(Figure 7, middle and right columns) [21].
Figure 4. Glomerular Electron Micrographs From Pdss2 Mutant and Control Mice. Electron micrographs from mutant and control mouse
kidney glomeruli; original magnifications all 10,000x; scale bar = 2 microns. A, B6, 362 days old; arrows show podocyte foot processes. B, B6.Pdss2kd/kd,
267 days old; arrows show regions of foot process effacement. C, B6.Pdss2loxP/loxP mouse, 248 days old; arrows show foot processes. D, B6.Podocin/
cre,Pdss2loxP/loxP 290 days old; arrows show regions of foot process effacement.
doi:10.1371/journal.pgen.1000061.g004
Renal Disease in Pdss2 Mutant Mice
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Unique to the CoQ biosynthetic defect, B6.Alb/cre,Pdss2loxP/loxP
mutants have upregulation of CoQ biosynthesis, likely in
compensation for their underlying CoQ deficiency. Similarly,
the substrates immediately prior to the Pdss2-encoded prenyldi-
phosphate synthase enzymatic block (such as farnesyl pyrophos-
phate) appear to get funneled toward alternative biochemical
pathways, as above. Interestingly, regulation of autophagy is
uniquely upregulated in the B6.Alb/cre,Pdss2loxP/loxP mutants,
supporting previously reported findings of mitophagy occurring
in these animals as characterized by endoplasmic reticulum
engulfing liver mitochondria [10]. Consistent with CoQ function
in both prooxidant and antioxidant roles, global expression
analysis demonstrates the upregulation of multiple cellular defense
pathways including the metabolism of P450 and glutathione,
ascorbate metabolism, as well as the degradation of bisphenol A,
limonene, pinene, and gamma-hexachlorocyclohexane. These
mutants also appear to have alterations in basic DNA metabolism,
as evidenced by upregulation of the metabolism of purines,
pyrimidines, nucleotide sugars, ribosomes, aminoacyl-tRNAs, and
RNA polymerase. Finally, four KEGG pathways appear on initial
inspection to be discordantly expressed between mouse Pdss2
mutants and C. elegans complex I subunit mutants (Figure 7, left
and middle columns, green highlight); however, none of these
pathways upregulated in B6.Alb/cre,Pdss2loxP/loxP were validated as
having altered expression in the independent C. elegans dataset
comprised of eight different complex I, II, and III respiratory
chain subunit mutants (Figure 7, right column).
Altered amino acid metabolism is further supported by
significant concentration differences among multiple amino acids
quantified in livers of B6.Alb/cre,Pdss2loxP/loxP mutants (Figure 8,
Panels C and D). Hepatic glutamate was lowered to less than half
the control value (p,0.01; Figure 8, Panel D). Glutamate
depletion could account for decreased levels of glutamine and
alanine (Figure 8, Panel D) that derive from glutamate via
glutamine synthetase and alanine aminotransferase, respectively.
Similarly, a loss of glutamate could lower hepatic concentrations of
phenyalanine, methionine, leucine, isoleucine and valine (Figure 8,
Panel C), each of which forms from glutamate by a specific
transaminase. The total absence of citrulline (Figure 8, Panel C)
suggests ureagenesis is compromised in Pdss2 mutant mice.
Similarly, the sole amino acid to be significantly increased was
the urea cycle precursor, aspartate (Figure 8, Panel C), with a
sharp reduction in the glutamate:aspartate ratio (1:4 vs 4:1) of
mutant vs control liver.
Pdss2 Missense Mutants Have No Clinical Manifestations
of Extra-Renal Disease
Histological sections of the brain, retina, liver, and skeletal
muscle of B6.Pdss2kd/kd mutants demonstrated no obvious
structural abnormalities. Skeletal muscle sections stained with
Gomori/trichrome and antibodies to muscle enzymes (ATPase,
NADH, SDH) showed no evidence of subsarcolemmal mitochon-
drial aggregates or other abnormalities. In addition, no differences
were observed in bone mineral density or concentration, lean body
mass, complete blood count, or liver transaminase (ALT) (data not
shown). Several significant differences were noted in the liver
amino acid levels of these animals (Figure 8, Panels A and B), but
these changes were not as intense or widespread as observed in
livers of B6.Alb/cre,Pdss2loxP/loxP mutants (Figure 8 Panels C and D).
The fact that most of these changes affected essential amino acids
– threonine, phenylalanine and isoleucine, for example – could
reflect albuminuria with concomitant nitrogen wasting and
relative protein deficiency in these animals.
Discussion
The occurrence of a kidney disease phenotype in B6.Podocin/
cre,Pdss2loxP/loxP but not B6.PEPCK/cre,Pdss2loxP/loxP mice resolves a
long-standing question regarding the cellular localization of the
primary defect in B6.Pdss2kd/kd mice [3,20]. Table 1 shows that a
primary defect in podocytes recapitulates the kd/kd disease
phenotype and is responsible for the development of nephrotic
syndrome, which was not the case for mice expressing the defect
primarily in renal tubular epithelium and hepatocytes (B6.PEPCK/
cre,Pdss2loxP/loxP). Hence, interstitial nephritis occurs as a conse-
quence of a Pdss2 defect in glomerular podocytes. Knocking out
the Pdss2 gene in podocytes resulted in a more severe phenotype
than that observed in mice homozygous for the Pdss2kd mutation
(Figure 4), as would be expected if the product of the missense
allele has at least some residual activity. Detection of CoQ9 and
CoQ10 in the kidneys of B6.Pdss2
kd/kd mice, while almost ten-fold
lower than age-matched B6 controls, suggests that the V117M
amino acid substitution mutation in the Pdss2kd gene product
retains partial activity (Figure 5).
That tubular dilatation and interstitial nephritis are downstream
consequences of a CoQ deficiency in podocytes is illustrated by
Figure 3. Our results suggest that CoQ deficiency negatively
impacts mitochondrial respiratory chain function, although loss of
CoQ antioxidant function may also be involved in pathogenesis,
which leads to podocyte death with important consequences for
kidney function. The slit diaphragm, which is dependent on
podocyte foot processes, is essentially destroyed, causing leakage of
various proteins normally maintained within the circulation, such
as serum albumin. Some of these molecules have deleterious effects
Table 1. Phenotypes of mice with conditional knockout and
control genotypes*
Genotype
Urine albumin
(mg/24 hrs) Nephritis
B6.Podocin/cre,Pdss2loxP/loxP 32.89 +/2 7.64 (28)** 1.80 +/2 0.29 (26)
B6.PEPCK/cre, Pdss2loxP/loxP 0.18 +/2 0.05 (18) 0.05 +/2 0.05 (20)
B6.LysM/cre, Pdss2loxP/loxP 0.12 +/2 0.01 (6) 0.33 +/2 0.08 (6)
B6.Alb/cre,Pdss2loxP/loxP 0.13 +/2 0.03 (6) 0.17 +/2 0.15 (6)
B6.Pdss2kd/kd 21.17 +/2 5.41 (6) 2.11 +/2 0.40 (9)
B6. Pdss2loxP/loxP 0.24 +/2 0.07 (7) 0.73 +/2 0.22 (11)
B6 0.12 +/2 0.01 (8) 0.58 +/2 0.18 (12)
*All mice at least 120 days old.
**Mean +/2 SEM; N is shown in parentheses.
doi:10.1371/journal.pgen.1000061.t001
Table 2. Plasma cholesterol levels in mice with conditional
knockout and control genotypes
Genotype Plasma cholesterol (mg/dl)
B6.Podocin/cre,Pdss2loxP/loxP 144 +/2 21.3 (7)
B6.Alb/cre,Pdss2loxP/loxP 94 +/2 7.1 (7)
B6. Pdss2loxP/loxP 61 +/2 5.5 (7)
All mice were at least 120 days old; data express mean +/2 SEM; N is shown
in parentheses. For B6.Podocin/cre,Pdss2loxP/loxP vs. B6. Pdss2loxP/loxP, t = 3.50 and
p= 0.004; for B6.Podocin/cre,Pdss2loxP/loxP vs. B6.Alb/crePdss2loxP/loxP, t = 2.09 and
p= 0.058; for B6.Alb/cre,Pdss2loxP/loxP vs. B6. Pdss2loxP/loxP, t = 3.34 and p= 0.006.
doi:10.1371/journal.pgen.1000061.t002
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on the collecting tubules, which leads to tubular dilatation and
dysfunction, release of inflammatory mediators, and development
of interstitial nephritis.
The results in Table 2 suggest that the elevation in serum
cholesterol that is characteristic of Pdss2kd/kd homozygotes [20] is not
entirely attributable to kidney disease, but likely results from
shunting of farnesyl diphosphate (one of the precursors in the CoQ
biosynthetic pathway immediately proximal to the Pdss2 enzymatic
block) to alternative pathways, primarily involving cholesterol
biosynthesis. This is supported by transcriptional profiling of
B6.Alb/cre,Pdss2loxP/loxP liver which demonstrated upregulation of
two pathways for which cholesterol is the starting substrate, namely
bile acid biosynthesis and steroid biosynthesis (Figure 7).
In light of the severe, multi-system phenotype of the child with
primary CoQ deficiency due to PDSS2 mutations [11], we
undertook an extensive phenotypic evaluation of B6.Pdss2kd/kd
Figure 5. CoQ Measurements in Pdss2 Missense, Conditional Knockout, and Strain-Matched Control Mice. CoQ measurements in
Pdss2kd/kd; Podocin/cre,Pdss2loxPloxP; PEPCK/cre,Pdss2loxPloxP; Alb/cre,Pdss2loxP/loxP; and strain-matched control mice (B6 and B6.Pdss2loxPloxP). A, Kidney
levels of CoQ9 and CoQ10 are significantly lower in B6.Pdss2
kd/kd (missense) mice than in B6 control mice. B, Kidney levels of CoQ9 and CoQ10 are
similar in B6.Podocin/cre,Pdss2loxPloxP; B6.PEPCK/cre,Pdss2loxPloxP; B6.Alb/cre,Pdss2loxP/loxP; and control mice. The 92-day-old controls are B6.Pdss2loxP/+,
and the 94-day-old control is B6.Pdss2loxP/loxP. C, Liver levels of CoQ9 in B6.Alb/cre,Pdss2
loxP/loxP mice were below 30 picomoles/mg protein (*) while
these same levels in B6.Podocin/cre,Pdss2loxPloxP and B6.PEPCK/cre,Pdss2loxPloxP mice were similar to those in control mice. The strains of the control
mice in are the same as those in panel B.
doi:10.1371/journal.pgen.1000061.g005
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spontaneous missense homozygous mutants. All studies were
performed in animals more than 120 days old, the time by which
renal dysfunction is present. No overt non-renal disease manifes-
tations could be detected, although significant deficiencies were
observed in their respiratory function and activity of isolated liver
mitochondria (Figure 6), as well as quantitative amino acid profiles
in liver (Figure 8). It remains possible that additional manifesta-
tions of CoQ deficiency would develop with time but do not
because of the high mortality of their renal disease. This possibility
is being further evaluated by prolonged observation of tissue-
specific conditional knockouts without renal disease.
Interestingly, B6.Alb/cre,Pdss2loxP/loxP liver-conditional knockout
mutants manifest no overt symptoms or signs of liver disease
through at least eight months of life. Nonetheless, focused
evaluations of the livers of these animals demonstrated substantial
(97%) knockdown of Pdss2 expression; pronounced CoQ9
deficiency (Figure 5) and significant impairment of complex I-
and complex II-dependent integrated respiratory capacity as well
as complex I-III and II-III enzyme activities with compensatory
increase in complex IV-dependent respiratory capacity in isolated
mitochondria (Figure 6). The relatively robust respiratory electron
transport chain activities are quite remarkable, given that CoQ9
was not detected over background in these liver lipid extracts. The
low levels of CoQ9 present in these animals must support
significant activities of complexes I, II, and III. Very small
amounts of CoQ support significant respiratory chain activity in
Figure 6. CoQ Deficiency Causes Mitochondrial Dysfunction in Pdss2 Mutant Mice. Impact of coenzyme Q deficiency on mitochondrial
function in B6.Pdss2kd/kd and B6.Alb/cre,Pdss2loxP/loxP mice compared to concurrent age- and strain-matched controls (B6 and B6.Pdss2loxP/loxP,
respectively). Panels A, B, and C demonstrate polarographic results of freshly isolated liver mitochondria with substrates which specifically interrogate
complex I-dependent (malate+glutamate), complex II-dependent (succinate), and complex IV-dependent (TMPD+ascorbate) OXPHOS capacity.
B6.Pdss2kd/kd missense mutants have impaired complex I- and complex II-dependent OXPHOS capacity by 23% and 33%, respectively, with a 19%
increase in complex IV-dependent OXPHOS capacity. B6.Alb/cre,Pdss2loxP/loxP mutants have impaired complex I- and complex II-dependent OXPHOS
capacity by 20% and 40% respectively, with a 43% increase in complex IV-dependent OXPHOS capacity. Values represent state 3 (near maximal)
oxygen consumption mean rate and standard error. Panel D summarizes electron transport chain activity assays for complexes I-III, II, III, and IV
performed on remaining aliquots of liver mitochondria frozen following completion of polarography. Similar to polarographic results, I-III enzyme
activity is significantly decreased by 19% in B6.Pdss2kd/kd missense mutants and by 41% in B6.Alb/cre,Pdss2loxP/loxP mutants when compared to pooled
controls. Complex IV enzyme activity demonstrates a trend toward increase by 11% in B6.Pdss2kd/kd missense mutants and by 23% in B6.Alb/
cre,Pdss2loxP/loxP mutants when compared to pooled controls, but does not reach the level of statistical significance, perhaps because of small sample
size (n = 2 for remaining mitochondria from B6.Alb/cre,Pdss2loxP/loxP mutants). As expected, no change is seen in complex II or III activity for either
mutant. Values represent mean enzyme activity and standard error. B6 and B6.Pdss2loxP/loxP ETC activity values were pooled to increase control sample
size following demonstration of no significant differences between these strains. Statistical analyses comparing mutants and controls were performed
by one-way ANOVA, where * indicates p,0.05 and ** indicates p,0.01.
doi:10.1371/journal.pgen.1000061.g006
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other models (yeast, nematode, isolated mitochondria). Liu et al.
[22] showed that hepatocytes in clk-1/+ heterozygous mice lose
heterozygosity (become clk-1 2/2), and these cells undergo clonal
expansion within the liver. These findings suggest that liver cells
perform quite adequately with low CoQ content.
A significantly altered cellular metabolism phenotype in liver of
B6.Alb/cre,Pdss2loxP/loxP mice was evidenced by concordant upre-
gulation of 43 biochemical pathways (Figure 7) with significant
deficiency of 9 amino acids (Figure 8). Taken together, these
alterations confirm that Pdss2 dysfunction is a nuclear gene-based
mitochondrial respiratory chain defect to which cellular adapta-
tion is occurring. Indeed, 15 key biochemical pathways were
concordantly upregulated on transcriptional profiling in this
murine model of primary mitochondrial dysfunction and in
previously reported C. elegans models of primary respiratory chain
dysfunction due to mutations in nuclear gene-encoded subunits of
complexes I, II, and III (Figure 7). These similarities spanning
evolution provides support that a transcriptional ‘‘signature’’ of
mutations in the respiratory chain appears to be stimulation of the
constituent components of oxidative phosphorylation, the enzymes
of the TCA cycle, and many pathways (e.g., glycolysis, amino acid
metabolism, fatty acid metabolism) that furnish substrate to it, as
well as stimulation of key cellular defense pathways such as
glutathione and P450 metabolism [21].
Global amino acid alterations in Pdss2 mutant liver further
suggest that significant impairment may be occurring in flux
Figure 7. Metabolic Pathway Alterations Are Seen by Expression Profiling in B6.Alb/cre,Pdss2loxP/loxP Mouse Liver. Global genome
expression profiling in B6.Alb/cre,Pdss2loxP/loxP mouse liver identifies concordant transcriptional alterations interpretable at the level of multiple
metabolic pathways, which suggest significantly altered intermediary metabolism occurs despite an apparent absence of symptomatic disease.
Extensive evolutionary concordance in upregulation of key biochemical pathways is seen in primary mitochondrial dysfunction, both in this
mammalian Pdss2 liver-conditional knockout model of coenzyme Q deficiency and in a previously reported C. elegans gas-1(fc21) missense mutant
model of primary complex I dysfunction [21]. Biochemical pathways as curated from the KEGG online database (http://genome.jp.kegg) are indicated
with the # of genes in each pathway (cluster size), normalized enrichment score (NES), statistical significance of altered pathway expression between
mutant and wildtype controls (p-value), and false positive percentage in the form of a false discovery rate (FDR q-value) according to GSEA. Pathways
are ranked by descending NES in the Pdss2 mutant (left data column). Comparison to previously reported complex I gas-1(fc21) missense C. elegans
mutant dataset (middle data column) and a ‘‘validation’’ C. elegans dataset of 8 different complex I, II, and III missense and RNAi-interference
generated mutants (right data column) is indicated by differential highlights [21]. Font color denotes a pathway as relatively upregulated (red),
downregulated (green), or unchanged (black).
doi:10.1371/journal.pgen.1000061.g007
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through key biochemical pathways, including glycolysis, the
pyruvate dehydrogenase reaction, the TCA cyle, and ureagenesis.
Changes in the hepatic amino acid profile were not qualitatively
dissimilar in B6.Alb/cre,Pdss2loxP/loxP mutants compared with those
of the B6.Pdss2kd/kd missense mutants, but alterations in the liver-
conditional knockout were far more widespread and intense
(Figure 8). The characteristic pattern in both mutants was a sharp
reduction of hepatic amino acid concentrations, which appear to
be related to a relative depletion in the hepatic concentration of
glutamate. Indeed, glutamate is the ‘‘pivot’’ of nearly all amino
acid metabolism as it furnishes amino groups to ketoacids to support
the concentrations of alanine, leucine, isoleucine, valine, and
phenylalanine, as well as to glutamine via glutamine synthetase. In
addition, glutamate rapidly enters the TCA cycle as a-ketoglutarate
either via transamination or the glutamate dehydrogenase pathway.
We propose that diminished glutamate may occur in Pdss2 mutants
due to their enhanced utilization of glutamate as a metabolic fuel in
response to a relative diminution in their glucose consumption rate
via glycolysis. It is recognized that in some tissues – particularly
kidney and brain – glutamate can become an important metabolic
substrate [23]. The significant reduction observed in alanine
concentration (Figure 8, Panel C) is consistent with this formulation,
since alanine carbon forms from pyruvate that is produced in
glycolysis. Similarly, the sharp reduction in the glutamate:aspartate
ratio in mutant liver implies an increase of hepatic oxaloacetate, a
TCA cycle intermediate which is the obligatory precursor both to
aspartate carbon as well as to the TCA cycle citrate synthetase
reaction. In other words, if glycolytic flux is relatively diminished in
the Pdss2 mutants, less pyruvate will be produced and flux through
pyruvate dehydrogenase will be attenuated, thereby limiting
availability of acetyl-CoA to the citrate synthase reaction, which
would augment the hepatic pool of oxaloacaetate and impair TCA
cycle flux. Diminished glutamate would also impede production of
N-acetylglutamate, an obligatory effector of the carbamylphosphate
synthetase reaction sequence in the mitochondrial segment of the
urea cycle that leads from ammonia to citrulline, the total absence of
which (Figure 8, Panel C) points to a compromise of ureagenesis in
the liver of B6.Alb/cre,Pdss2loxP/loxP mice. It is of interest in this regard
that the sole amino acid to be significantly increased is aspartic acid
(Figure 8, Panel C), since a failure of citrulline synthesis would
sharply curtail flux through cytosolic argininosuccinate synthetase, a
step in the urea cycle that utilizes both citrulline and aspartate as
precursors. The diminished glutamate:aspartate ratio highlighted
above also denotes compromised flux through the hepatic urea cycle,
to which aspartate is a major nitrogen donor. Additional
investigations are necessary and underway to verify the extent to
which metabolic flux is impaired in Pdss2CoQ biosynthetic mutants.
We conclude that the Pdss2kd allele causes a milder phenotype in
homozygous mice than that observed in the homologous human
case [11]. What is especially puzzling about the Pdss2kd/kd mutant
mouse is why an intermediate level of activity in oxidative
phosphorylation should uniquely affect podocytes, a cell type not
previously characterized by unusually high levels of respiratory
activity. However, it is clear that CoQ concentrations and
Figure 8. Pdss2Mutants Have Altered Amino Acid Profiles in Liver. Pdss2 mutants have altered amino acid profiles in liver. Quantitative liver
amino acid analysis detects significant differences in B6.Pdss2kd/kd missense mutants compared with B6 controls (Panels A and B), as well as in B6.Alb/
cre,Pdss2loxP/loxP mutants compared with B6.Pdss2loxP/loxP controls (Panels C and D). To better demonstrate differences in all amino acids, results for
three amino acids in highest abundance are shown separately (Panels B and D) with a greater scale compared to that used for the remainder of the
amino acids present in relatively lower abundance (Panels A and C). Values represent mean +/2 SEM. Statistical analyses comparing mutants and
controls were performed by Student’s t-test, where * indicates p,0.05 and ** indicates p,0.01.
doi:10.1371/journal.pgen.1000061.g008
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intermediary metabolism are significantly altered in the missense
mutants. It is also interesting that the Pdss2kd/kd mouse is a
mammalian model of mitophagy, a process recently described in
yeast to involve the preferential degradation of impaired mitochon-
dria before initiating cell death [24]. The occurrence of a
subsequent intense inflammatory response suggests that autoanti-
gens are exposed by autophagy to initiate either an innate or
adaptive immune response. The inflammatory response is not the
primary cause of the renal disease, but appears to be the mechanism
used to collect and dispose of cellular debris. Availability of
B6.Pdss2loxP/loxP mice will now permit future investigations into the
specific sites of CoQ deficiency and tissue damage, particularly in
the central nervous system and skeletal muscle, which lead to the
heterogeneous but severe consequences of primary mitochondrial
disease as observed in the human PDSS2 patient.
Materials and Methods
Construction of Vectors
The targeting construct and Pdss2loxP/loxP construct were made
as follows. The 11.8 kb linearized DNA containing the Pdss2 exon
2 was from a bacterial artificial chromosome (BAC #RP23-
256E1) with digestion of BamH 1 and Dra III, and was subcloned
into pBlueScript vector. The cassette containing loxP-neo-loxP
was inserted into an Aat II site, and a loxP was introduced into an
Xho I site. The PdssloxP/loxP targeting construct is depicted in
Figure 1 and contains approximately 7 kb of homology regions.
This linear targeting construct was electroporated into R1 ES cells.
Stably transfected cells were isolated after selection in G418 (350
ul/ml, Gibco), and 384 clones were screened for the desired
homologous recombination event with PCR. Chimeric mice were
generated by aggregation of ES cells with morulae of B6 mice, and
the modified allele was passed through the germline by breeding
chimeras to B6 mice. The genotypes of all offspring were analyzed
by polymerase chain reaction using DNA from the ear of mice or
the yolk sac of embryos. The k/oF and k/oR primers for
determination of Exon 2 (PCR product of 440 bp) were 59-
GGAGGTTGAGTCCCTGTGTC-39 and 59- GCAGGAAAT-
CAGTGGGACTC-39 respectively. PCRs were carried out for 30
cycles (94uC for 20 s, 60uC for 30 s, 72uC for 1 min) in a buffer
containing 1.5 mM MgCl2.
Mice
Mice homozygous for the floxed gene (B6.Pdss2loxP/loxP) were
crossed with partners that expressed cre under the control of a zona
pelucida glycoprotein 3 promoter (C57BL/6-Tg(Zps-cre)93 Knw/
J; Zp3/cre), obtained from The Jackson Laboratory (Bar Harbor,
ME), which caused the floxed gene to be deleted in all tissues.
Podocyte-specific knockouts (B6.Podocin/cre,Pdss2loxP/loxP), were
obtained by crossing mice homozygous for the floxed gene with
partners that expressed cre under the control of the Podocin
promoter [25]. The mutation was targeted to the renal proximal
tubular epithelial cells (as well as a subset of hepatocytes) by
mating B6.Pdss2loxP/loxP mice with partners that express a PEPCK/
cre transgene [26]; to hepatocytes by utilizing mice with an
albumin/cre promoter (B6.Cg-Tg(Alb-cre)21 Mgn/J (Alb/cre)),
obtained from The Jackson Lab; or cells of the myeloid
lineage with mice that express cre under the control of the
lysozyme M promoter (B6.129P2-Lyzstm1(cre)Ifo/J; LysM/cre [27]
obtained from The Jackson Laboratory. Mice with the
Pdss2kd/kd missense mutation on the B6 background have been
previously reported [7,10]. All procedures were approved by the
Institutional Animal Care and Use Committee of the University of
Pennsylvania.
Albumin Assay
A mouse albumin ELISA kit was obtained from Bethyl
Laboratories Inc. Briefly, ELISA plates (Nunc, No: 442404) were
coated overnight with goat anti-mouse albumin antibody (10 ml /
ml) in bicarbonate buffer pH 9.6. Wells were washed with distilled
water, blocked with PBS-1% BSA, washed with PBS-0.05%
Tween 20, and 100 ml of serially diluted samples or standards
added for 1 hour at room temperature. Plates were then washed
using PBS-0.05% Tween 20, and incubated with 100 ml of HRP-
conjugated goat anti-mouse albumin antibody at room tempera-
ture for 1 hour. After further washing with PBS-0.05% Tween 20,
wells were incubated with 100 ml ABTS solution at room
temperature for 20 min, then with 100 ml 2 M H2SO4 stopping
solution and the plate was read with an ELISA reader at 405 nm.
Histology
Kidneys from mutant and control mice were fixed in formalin,
paraffin-embedded, and 4 mm sections through the longitudinal
axis of each kidney were prepared and stained with hematoxylin
and eosin. The sections were examined blindly and scored as
follows: 0 = no tubular dilatation and no mononuclear cell
infiltrates; 1 = small focal areas of cellular infiltration and tubular
dilatation involving less than 10% of the cortex; 2 = involvement of
up to 25% of the cortex; 3 = involvement of up to 50% of the
cortex; 4 = extensive damage involving more than 75% of the
cortex. Coronal sections of the brain were stained by H & E. To
examine the retina, anesthetized mice were perfused through the
heart with freshly prepared 2% PFA+2% glutaraldehyde in 0.2 M
sodium cacadylate buffer (pH 7.4). Eyes were removed and
eyecups were fixed in the same buffer for 4 hours at room
temperature. Tissues were then dehydrated in a graded ethanol
series, infiltrated, and embedded in EMbed812 (Electron Micros-
copy Sciences). Sections of 1–2 m in thickness were cut and stained
with toluidine blue. Liver sections were examined after H & E and
Oil Red O staining. Skeletal muscle was stained by Gomori/
trichrome stain, and with antibodies to ATPase, SDH, NADH,
and acid phosphatase.
Laser Capture Microdissection and PCR Amplification
Mouse kidney sections 6 mm in thickness were cut onto
nuclease-free Membrane Slides for Laser microdissection (Molec-
ular Machines and Industries, Lenor City VA). After hematoxylin
staining, laser microdissection of glomeruli or collecting tubules
was done using the SL mcut system, and samples were collected
onto adhesive caps of 0.5 ml tubes as previously described [25].
Microdissected samples were incubated with 50 ml lysis buffer
containing 10 mM Tris HCl (pH 8.3), 50 mM KCl, 2 mM
MgCl2, 0.1 mg/ml gelatin, 0.45% NP40, 0.45% Tween 20, 6
ml/ml Proteinase K overnight at 55uC. 0.5 ml lysis buffer was used
for each PCR reaction. Primers with the PCR product containing
exon 2 of Pdss2 were as follows: forward, 59-AGCTGTGCA-
CATGTGTGTGA-39 and reverse, 59-AAGCTTTTATGTGC-
CCGATG-39. Primers with the PCR product containing exon 4 of
Pdss2 were: forward, 59-TGCAGGAGGATTATCACAGC-39
and reverse, 59-TGCACATCAATTTTTCCCATT-39.
Electron Microscopy
As previously described [28], kidney tissue samples were fixed in
2.5% glutaraldehyde and 2.0% paraformaldehyde in 0.1 M
sodium cacodylate buffer, pH 7.4, overnight at 4uC. After three
cacodylate buffer washes, the samples were post-fixed with 2.0%
osmium tetroxide in 0.1 M cacodylate buffer for one hour at 4uC.
After two additional sodium cacodylate washes and a wash in
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dH2O, samples were stained with 2% aqueous uranyl acetate for
30 minutes at room temperature. Samples were rinsed again in
H2O subsequent to dehydration in graded ethanols, and
infiltration and embedding in Embed-812 (Electron Microscopy
Sciences, Fort Washington, PA). All sections were examined in a
JEOL 1010 electron microscope, and digital images were recorded
with a Hamamatsu camera system.
CoQ Measurements in Mouse Kidney and Liver
Homogenates
Whole kidneys and livers were dissected from sacrificed mice
and were stored at 280uC until homogenization. Individual
kidneys or lobes of livers were placed in 5 mL of 1X PBS, pH 7.4
(137 mM NaCl, 8 mM Na2HPO4, 2.7 mM KCl, 1.5 mM
KH2PO4) 4uC, and tissues were homogenized a total of 10 strokes
with a tight-fitting Teflon pestle rotating at maximal speed with a
Fisher Scientific Lab Stirrer LR400A. The homogenate was
centrifuged at 10006g for 5 minutes. The supernatants were
removed to fresh vials, and protein concentrations were measured
by the bicinchoninic acid assay (Pierce, Rockford, IL). Aliquots of
each homogenate were transferred to 50 ml glass tubes and stored
at 280uC until extracted. Lipid extractions were performed on
CoQ9 standards, CoQ10 standards, and mouse tissue homogenates
by adding the same amount of coenzyme CoQ6 internal standard
along with 0.5 ml water, 9 ml methanol, and 6 ml petroleum
ether to each. Mixtures were vortexed for 1 min, centrifuged at
9106g, and the top layer of petroleum ether was removed and
saved in a separate vial. Fresh petroleum ether (6 ml) was added to
each vial containing the aqueous phase and vortexed for 1 min.
The vials were subjected to centrifugation as before and the second
petroleum ether layer removed. The process was repeated once
more, and the three pooled petroleum ether fractions were dried
under nitrogen and resuspended in 200 ml methanol. The
quinones were then separated and quantified by HPLC connected
to an electrochemical detector as described [29], with the
following exceptions: the precolumn electrode was the only
electrode used and was set at +650 mV to oxidize all hydroqui-
nones, and a Gilson 118 UV/Vis detector was utilized to detect
quinones (275 nm) as they eluted from the column. The amount of
CoQ9 and CoQ10 in the standards and samples was normalized to
the amount of CoQ6 recovered in the individual lipid extracts.
Integrated Respiratory Capacity Analysis of Freshly
Isolated Liver Mitochondria
Mice were sacrificed by cervical dislocation without general
anesthetic, since anesthetics may exacerbate mitochondrial
dysfunction in primary mitochondrial disease [30]. Mouse liver
mitochondria were isolated in a similar manner as described
previously for rat liver mitochondria [31]. Briefly, livers were
immediately dissected and collected in MSM buffer (220 mM
mannitol, 70 mM sucrose and 5 mM MOPS, pH: 7.4). All
subsequent mitochondrial isolation procedures were done on ice.
Livers were washed twice with MSM, finely minced, and then
homogenized in MSM-E (MSM containing 2 mM EDTA) with 2
slow strokes using a tight-fitting Teflon pestle in a glass Potter/
Elvehjem tissue grinder (DuPont, Wilmington, Delaware) at
400 rpm using an IKA RW20 digital homogenizer (Cole-Palmer,
Illinois). Following initial centrifugation at 300 g610 minutes at
4uC, the supernatant was collected and centrifuged at
7000 g610 minutes at 4uC (Eppendorf 5810R centrifuge, rotor
F34-6-38, Hamburg, Germany). The pellet containing mitochon-
dria was then washed twice in MSM with high speed
centrifugation at 7000 g610 minutes at 4uC. 2% protease
inhibitor cocktail was added to the final washed pellet preparation
(SIGMA, St. Louis, MO). Protein concentration was determined
by Lowry assay [32]. Mitochondrial oxygen uptake by polarog-
raphy using a clark-type electrode (Oxytherm, Hansatech
Instruments, UK) was performed on freshly isolated mitochondria
at 30uC, as previously described [30]. Substrates used were
malate+glutamate, succinate, and TMPD+ascorbate to assess
complex I-, II-, and IV- dependent integrated respiratory capacity,
respectively. State 3 oxidative phosphorylation (OXPHOS)
respiratory rates were measured in the presence of ADP to
approximate maximal mitochondrial capacity. Mean state 3 rates
with standard errors were calculated from at least duplicate
tracings for each electron donor substrate for liver mitochondria
isolated from 6 B6.Pdss2kd/kd missense mutants, 3 B6. Alb/
cre,Pdss2loxP/loxP conditional knockout mutants, and a total of 9
concurrent age- and strain-matched controls (66B6 and
36B6.Pdss2loxP/loxP, respectively). As no statistically significant
differences were detected in state 3 rates for any substrate between
B6 and B6.Pdss2loxP/loxP controls, all control data (B6+B6.Pdss2loxP/
loxP) were used for comparative analysis with each mutant strain.
Comparison of means was done by one-way ANOVA assuming
equal variance (SPSS v.12.0, Chicago, IL).
Liver and Kidney Mitochondrial Enzyme Activity Analyses
Following polarographic analysis of isolated liver mitochondria,
as described above, remaining mitochondrial aliquots were
promptly frozen in 280uC and subsequently available for study
on 4 B6.Pdss2kd/kd missense mutants, 2 B6.Alb/cre,Pdss2loxP/loxP
conditional knockout mutants, and a total of 6 concurrent age-
and strain-matched controls (46B6 and 26B6.Pdss2loxP/loxP,
respectively). Duplicate frozen aliquots of each strain were studied,
when available. Mitochondria from single whole kidney homog-
enates were isolated in a similar fashion as described above for
liver mitochondria with the exception that the renal capsule was
first manually removed by squeezing. As yields of mitochondria
were insufficient to permit polarography with all substrates as
described above, kidney mitochondria quality was assessed for 3
representative strains by polarography with malate+glutamate and
succinate to demonstrate robust state 3 rates, respiratory control
ratios . 3 and . 2, respectively, and ADP/O malate+glutamate
. 3.5.
Enzyme assays for citrate synthase and the partial reactions of
electron transport were performed at 37uC in a total reaction
volume of 1 mL using standard methods [33]. Absorbance
changes were continuously monitored using the dual-beam mode
of an OLIS-converted DW2a spectrophotometer. Sensitivity to
enzymatic inhibitors was used to confirm assay specificity.
Complex I+III was measured at 550 nm minus 540 nm (extinction
coefficient 19.0 mM21 cm21) as rotenone-sensitive NADH-cyto-
chrome c oxidoreductase. Complex II+III was measured at
550 nm minus 540 nm 19.0 mM21 cm21) as antimycin A-
sensitive succinate-cytochrome c oxidoreductase [7,8]. Aliquots
of mitochondria were preincubated with succinate for 10 minutes
before assay of complex II+III. Complex III was measured at
550 nm minus 540 nm (19.0 mM21 cm21) using decylubiquinol
as antimycin A-sensitive ubiquinol-cytochrome c oxidoreductase.
Complex IV was measured at 550 nm minus 540 nm
(19.0 mM21 cm21) as azide-sensitive ferrocytochrome c oxidase.
Citrate synthase was measured at 412 nm minus 360 nm
(13.6 mM21 cm21) using 5,5-dithio-bis(2-nitrobenzoic acid) to
detect free sulfhydryl groups in coenzyme A. Individual enzyme
activities are reported in nmol/min/mg protein. As no statistically
significant differences were detected in activities for any substrate
between B6 and B6.Pdss2loxP/loxP liver mitochondria controls, all
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control data (B6+B6.Pdss2loxP/loxP) were used for comparative
analysis with each mutant strain. Comparison of means was done
by paired t-test.
Pdss1 and Pdss2 Expression Analysis
Standard precautions were followed to avoid contamination or
degradation of RNA samples [34]. Total RNA was extracted from
30 to 90 mg aliquots of freshly isolated liver collected from each
animal sacrificed for polarographic analysis (see above), and liver
from an additional three animals each with genotypes B6.Alb/
cre,Pdss2loxP/loxP B6.Pdss2loxP/loxP , B6, and B6.Pdss2loxP/loxP to verify
Pdss1 expression results. In addition, RNA was extracted from
single whole kidneys of three B6.Pdss2kd/kd missense, three
B6.Podocin/cre,Pdss2loxP/loxP mutant mice, three B6 controls, and
three B6. Pdss2loxP/loxP controls using Trizol reagent (Invitrogen
Corporation, Carlsbad, CA) and purified in RNeasy spin columns
(Qiagen, Inc., Valencia, CA). Total RNA concentration and
dissolution were determined spectrophotometrically at 230 nm,
260 nm, and 280 nm (NanoDrop ND-100 Spectrophotometer
v3.1.2, NanoDrop Technologies, Inc., Wilmington, DE). 10 mg of
total RNA was DNase-treated using a TURBO DNA-free kit
(Ambion Inc., Austin, TX). 1.1 mg of DNase-treated RNA was
reverse-transcribed in 20 ml reaction mixtures to generate cDNA
using a High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Foster City, CA). 40 ng of cDNA was used per
quantitative PCR (qPCR) reaction containing Taqman gene
expression MGB probes with FAM dye-labeled assays for both
endogenous (mouse b-actin Mm02619580_g1) and target (mouse
Pdss1 Mm00450958_m1 or Pdss2 Mm01191894_m1) genes, as
well as Taqman Universal PCR Master Mix (Roche, Branchburg,
NJ), per Applied Biosystems standard protocol (Applied Biosys-
tems, Foster City, CA). Real-time analysis was performed on an
SDS-7500 qPCR machine (Applied Biosystems, Foster City, CA).
Sequence Detection Software 1.2.3 version was used for relative
quantitation gene expression analysis (Applied Biosystems, Foster
City, CA). Relative gene expression is reported as the mean and
range of individual mutant strains each compared with pooled
age- and strain-matched controls.
Biochemical Pathway Expression Profiling Microarray
Analysis
Aliquots of total RNA were prepared from the same 3 B6.Alb/
cre,Pdss2loxP/loxP mutants and 3 B6.Pdss2loxP/loxP controls subjected
to mitochondrial studies as described above. The C. elegans
Genome Array was utilized for expression microarray analysis
(Affymetrix, Inc, Santa Clara, CA). Affymetrix probe-level data
was normalized and summarized in dChip using PM-only model
to obtain a single log2-transformed intensity value per probe set
per array (hyyp://biosun1.harvard.edu/complab/dchip). The
processed data was sent to gene set enrichment analysis (GSEA)
for cluster analysis while genes were ranked by the built-in signal-
to-noise function (GSEA v. 2.0, Broad Institute, Cambridge, MA).
Clusters were designed to represent M. musculus genesets relevant
to human metabolic pathways. Genesets were curated from
biochemical pathway data publicly available from Kyoto Ency-
clopedia of Genes and Genomes (KEGG) (www.genome.jp/kegg).
While 102 KEGG pathways were identified, only 95 genesets
contained 5 or more transcripts to meet criteria for inclusion in the
analysis. C. elegans microarray analysis was performed as previously
reported well-characterized mitochondrial complex I, II, and III
missense and RNA-interference generated hypomorphic mutants
[21]. All microarray expression data is available in a publicly
available MIAME-compliant database (GEO superSeries
GSE9967 for C. elegans arrays and GEO accession GSE10904
for M. musculus arrays).
Quantitative Amino Acid Profiling in Liver
Wedges of liver (,400 mg) were immediately frozen in 280uC
and homogenized in 4 ml aliquots of 4% perchloric acid that
contained e-aminocaproic acid (100 mM) as internal standard.
After centrifugation to remove protein, supernatants were adjusted
to pH 6–7 with KOH, then centrifuged again to remove
precipitated KClO4. Amino acids were measured in the resulting
supernatant by high performance liquid chromatography (HPLC)
using precolumn o-phthalaldehyde derivatization with fluorescent
detection (Varian, Palo Alto, CA) [35]. The protein pellet was
dissolved in 1N NaOH and results were normalized to protein as
determined by Lowry assay [32]. Means were compared with a
Student’s t-test.
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